Why the study?
Does metabolic syndrome affect subclinical atherosclerosis collectively as a latent factor or individually through its components in asymptomatic middle-aged adults?
Population
573 adults asymptomatic for cardiovascular disease or stroke, recruited from random samples of employees…
Design
Cohort
Follow-up
3 years (three examinations at 1.5-year intervals)
Authors
Loading...
May support evaluating individual metabolic syndrome components over the collective syndrome for subclinical atherosclerosis; leaves open gender-specific pathway validation in prospective cohorts.
Does metabolic syndrome affect subclinical atherosclerosis collectively as a latent factor or individually through its components in asymptomatic middle-aged adults?
The atherogenic effects of metabolic syndrome on subclinical atherosclerosis are driven by its individual components rather than a single latent syndrome, with distinct gender-specific pathways such as central obesity in men and triglycerides in women.
Amy Z. Fan (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: